This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Texas Tech University System. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Inventor Ke Wen
Introduction
Ke Wen is an accomplished inventor based in Harrison, NY (US). He has made significant contributions to the field of vaccine development. His innovative work focuses on creating self-attenuated prophylactic and therapeutic vaccines against various pathogens.
Latest Patents
Ke Wen holds a patent for a self-attenuated therapeutic vaccine. This invention includes a live, self-attenuated therapeutic vaccine, virus, and methods of making and using the same. The patent describes an isolated virus that comprises a viral genome expressing one or more viral antigens. Additionally, it features an artificial microRNA 30 (amiR-30) expression cassette inserted into a viral neuraminidase (NA) or a viral non-structural (NS) gene segment. This cassette expresses an amiR-30 that specifically inhibits the expression of a host gene essential for influenza virus replication in host cells. He has 1 patent to his name.
Career Highlights
Ke Wen is affiliated with the Texas Tech University System, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on public health and disease prevention.
Collaborations
Ke Wen collaborates with Mingtao Zeng, contributing to the advancement of vaccine technology and research.
Conclusion
Ke Wen's innovative contributions to vaccine development highlight his commitment to improving health outcomes through scientific research. His work exemplifies the importance of innovation in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile